
Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HTSUF · as of Jun 8, 2026
Key Statistics
Explore Hisamitsu Pharmaceutical Co., Inc. Data
htsuf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
htsuf competitorsStock Performance
Full HistoryAbout Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, S…
what is hisamitsu pharmaceutical co., inc. · htsuf stock overview · hisamitsu pharmaceutical co., inc. company profile · who is hisamitsu pharmaceutical co., inc. ceo · htsuf OTC · hisamitsu pharmaceutical co., inc. headquarters · hisamitsu pharmaceutical co., inc. business segments
About Stock Overview & Key Data
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Sep 23, 2010. As of the latest trading session, HTSUF stock price is $29.00, with a market capitalization of $2.0B. The stock has returned -10.22% over the past 12 months and +0.00% year-to-date.
In fiscal year 2026, Hisamitsu Pharmaceutical Co., Inc. reported revenue of $163.5B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hisamitsu Pharmaceutical Co., Inc. (HTSUF) stock price is $29.00. The stock is traded on OTC under the ticker symbol HTSUF. The 52-week range is $28.94 – $32.30.